Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Clinical trial NCT05674656 · RECRUITING
Trial details
- NCT number
- NCT05674656
- Sponsor
- ViiV Healthcare
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2026-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.